Kirsten Fleischmann is a Cardiology physician affiliated with University of California, San Francisco. OpenAlex indexes 386 publications with 16,800 citations (h-index 43). By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
86.8%Statin32.3%Atorvastatin Calcium56%Rosuvastatin Calcium29%Pravastatin Sodium16%Part D<11 patientsBeta blocker17.7%Metoprolol Succinate65%Carvedilol19%Metoprolol Tartrate16%Part D<11 patients+ 5 more classes in this area
Blood & clotting
13.2%Factor Xa inhibitor13.2%Eliquis80%Xarelto20%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 1997–2012 per NIH RePORTER. The latest:
- Novel Risk Markers in Primary Prevention of Coronary Artery Disease
University of California, San Francisco
FY2012$166,169R21HL112255 - Novel Risk Markers in Primary Prevention of Coronary Artery Disease
University of California, San Francisco
FY2011$218,419R21HL112255 - PASSIVE SMOKING AND OUTCOMES IN CONGESTIVE HEART FAILURE
University of California San Francisco
FY2005$8,418M01RR000079
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery
Journal of the American College of Cardiology
2024 - Comparative cost-effectiveness of non-invasive imaging tests in patients presenting with chronic stable chest pain with suspected coronary artery disease: a systematic review
European Heart Journal - Quality of Care and Clinical Outcomes
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Emmanuelle Waubant, MD
University of California, San Francisco
Joel Palefsky, MD
University of California, San Francisco
Peter Hunt, MD
University of California, San Francisco
Owen Wolkowitz, MD
University of California, San Francisco
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”